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Functional InsP3 receptors that may modulate
excitation–contraction coupling in the heart
Peter Lipp*, Mika Laine*†, Stephen C. Tovey*, Kylie M. Burrell*,
Michael J. Berridge*, Wenhong Li‡ and Martin D. Bootman*§
The roles of the Ca2+-mobilising messenger inositol
1,4,5-trisphosphate (InsP3) in heart are unclear,
although many hormones activate InsP3 production in
cardiomyocytes and some of their inotropic,
chronotropic and arrhythmogenic effects may be due to
Ca2+ release mediated by InsP3 receptors (InsP3Rs)
[1–3]. In the present study, we examined the expression
and subcellular localisation of InsP3R isoforms, and
investigated their potential role in modulating
excitation–contraction coupling (EC coupling). Western,
PCR and InsP3-binding analysis indicated that both
atrial and ventricular myocytes expressed mainly type II
InsP3Rs, with approximately sixfold higher levels of
InsP3Rs in atrial cells. Co-immunostaining of atrial
myocytes with antibodies against type II ryanodine
receptors (RyRs) and type II InsP3Rs revealed that the
latter were arranged in the subsarcolemmal space
where they largely co-localised with the junctional
RyRs. Stimulation of quiescent or electrically paced
atrial myocytes with a membrane-permeant InsP3 ester,
which enters cells and directly activates InsP3Rs,
caused the appearance of spontaneous Ca2+-release
events. In addition, in paced cells, the InsP3 ester
evoked an increase in the amplitudes of action
potential-evoked Ca2+ transients. These data indicate
that atrial cardiomyocytes express functional InsP3Rs,
and that these channels could modulate EC coupling.
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Results and discussion
Ratiometric PCR was used to investigate the relative
levels of InsP3R mRNA in various atrial and ventricular
preparations (Figure 1a). Type II InsP3Rs were the pre-
dominant species from isolated atrial and ventricular
myocytes. Atrial and ventricular myocardium revealed an
almost equal proportion of type I and II InsP3R mRNA.
The increased fraction of type I mRNA in the whole
myocardium in comparison with the isolated myocytes most
probably reflected contributions from cells other than the
working myocardium, such as endothelial cells (Figure 1a).
All three InsP3R isoforms were also detected in western
blots of atrial and ventricular myocardial tissue with
isoform-specific antibodies, with types I and II InsP3Rs
being the most abundant. The western blots indicated that
atrial myocytes displayed an approximately sixfold higher
expression of type II InsP3Rs than ventricular myocytes
(Figure 1b). A similar relative abundance of InsP3Rs in
atrial myocytes was observed in binding studies. [3H]InsP3
bound specifically to microsomes derived from atrial and
ventricular tissue (Figure 1c, open symbols). Scatchard
analysis revealed single InsP3-binding sites with similar
affinity in both atrial (Kd 7.2 nM; Bmax of 1.8 pmol/mg) and
ventricular (Kd 6.8 nM; Bmax 0.35 pmol/mg) myocardium.
The higher specific InsP3 binding to atrial cells was also
observed with purified myocytes (Figure 1c; closed
symbols). Consistent with the apparently greater number of
InsP3Rs in atrial myocytes, we found that populations of
permeabilised isolated atrial myocytes displayed a robust
Ca2+ release upon addition of 10 µM InsP3, whereas such a
Ca2+ release could not be detected from populations of ven-
tricular myocytes (Figure 1d). 
The data presented above concur with previous observa-
tions of InsP3R expression in cardiac myocytes, and in par-
ticular the specific presence of type II InsP3Rs [4].
Despite the substantial body of evidence for InsP3R
expression in cardiac myocytes, however, their subcellular
location and potential role is controversial [5]. As we were
able to demonstrate InsP3-induced Ca2+ release and sub-
stantial levels of InsP3R expression in atrial myocytes, we
sought to determine the subcellular location of InsP3Rs
and investigate their potential for releasing intracellular
Ca2+ stores in these cells. 
To discern more clearly the subcellular location of
InsP3Rs in atrial myocytes, we compared their distribu-
tion with that of type II RyRs — the main Ca2+-release
channels underlying cardiac EC coupling [6]. Immunos-
taining atrial myocytes with type II RyR-specific antibod-
ies revealed a banded pattern of RyRs perpendicular to
the longitudinal axis of the myocytes (Figure 2a). This
banding pattern reflects RyRs located along the regularly
arranged sarcoplasmic reticulum. In addition, strong
immunoreactivity was observed in close proximity to the
sarcolemma (Figure 2a). Thus atrial myocytes seemed to
possess two populations of RyRs, one in a subsarcolemmal
location and another deeper in the cytosol. Earlier studies
of the sarcoplasmic reticulum (SR) microarchitecture in
atrial myocytes reported a junctional component of the SR
that forms diadic couplings with the plasma membrane,
and a non-junctional component along the Z-band project-
ing into deeper layers of the cell [7]. We therefore con-
cluded that those RyRs close to the plasma membrane
represent junctional RyRs probably facing the L-type
Ca2+ channels, whereas the remaining RyRs depict the
non-junctional SR. Ventricular myocytes also showed a
banded pattern of type II RyR immunoreactivity. In this
case, however, the banding pattern was due to RyRs dis-
tributed along the T-tubules that conduct the action
potential inside the myocyte. The subsarcolemmal RyR
staining observed in atrial myocytes was apparent in some
ventricular cell sections, but was less obvious than in atrial
cells (data not shown).
Type II InsP3Rs in atrial myocytes had a markedly differ-
ent distribution to that of RyRs. Significant levels of
InsP3R staining were observed around the subsarcolem-
mal region of the cells. Almost no staining was apparent
deeper within the myocytes. Co-staining atrial myocytes
for type II RyRs (Figure 2b) and type II InsP3Rs
(Figure 2c) revealed that the Ca2+ channels were often in
overlapping positions in the subsarcolemmal region
(Figure 2d; n = 10). Volume-rendered images of part of a
single atrial myocyte stained for both RyRs and InsP3Rs
(Figure 2e,f) revealed that the InsP3R distribution was
mostly discontinuous spots, but again confirmed that both
Ca2+-release channels were found within micrometre dis-
tances of each other beneath the sarcolemma. These data
indicate that because of their large excess, RyRs in atrial
myocytes are not always in proximity to InsP3Rs. InsP3Rs
are, however, mainly localised with RyRs, although there
were some spots of InsP3Rs staining that did not overlap
with RyRs (Figure 2e,f).
Although many hormones increase InsP3 levels inside car-
diomyocytes, their action is difficult to examine since they
have pluripotent effects [3]. Therefore, to investigate the
consequences of InsP3R activation in isolation we used a
membrane-permeant InsP3 ester (InsP3BM; 10 µM) that
we and others have previously shown to specifically acti-
vate InsP3Rs [8,9]. EC coupling in striated muscle cells
involves the spatiotemporal recruitment of elementary
Ca2+ signals known as ‘Ca2+ sparks’ [10]. These Ca2+
sparks, which reflect the opening of clusters of RyRs on
the sarcoplasmic reticulum, can occur spontaneously in
resting myocytes [11]. Incubation of electrically non-
paced atrial myocytes with InsP3BM increased the
number of spontaneous Ca2+ sparks sevenfold within
5 minutes (Figure 3a–c). InsP3BM increased the fre-
quency of Ca2+ sparks at sites that were active before
application of the ester (marked by the asterisks in
Figure 3f,g), and also recruited previously quiescent Ca2+
spark sites (Figure 3d–g), which were mainly located in a
subsarcolemmal position, where InsP3Rs and junctional
RyRs were found (Figure 2).
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Figure 1
Characterisation of InsP3R expression in cardiac cells. (a) Ratiometric
PCR analysis of InsP3R isoforms in different cardiac tissues. The data
are presented as relative proportions of each InsP3R isoform
expressed in each cell or tissue type. (b) Western blot analysis of rat
ventricular (V) and atrial (A) myocardium using antibodies specific for
type II InsP3Rs. (c) [3H]InsP3 binding to rat atrial (open circles) and
ventricular (open squares) myocardial microsomes, and isolated atrial
(filled circle) and ventricular (filled square) myocytes. Data were
obtained from single binding experiments. Similar results were
obtained in three independent experiments for each cell or tissue.
(d) Responses of permeabilised isolated atrial (circles) and ventricular
(squares) myocytes to 10 µM InsP3 (InsP3 addition is indicated by the
bar at the top). The results are from a single experiment, typical of
responses observed in three independent experiments.
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The recruitment of Ca2+ sparks by InsP3BM supports
earlier findings that InsP3Rs can mobilise sarcoplasmic
reticulum Ca2+ stores [2,12]. More controversial, however,
is the idea that InsP3 may modulate EC coupling (see for
example [1]). When electrically paced atrial myocytes
were stimulated with InsP3BM (10 µM), we observed a
significant increase in the amplitude of action potential-
evoked Ca2+ transients within 2 minutes (Figure 4). In
addition, InsP3BM also caused the generation of sponta-
neous Ca2+ transients between action potentials. This
effect became more prevalent with longer ester incuba-
tions (compare traces recorded at 2 minutes and 5 minutes
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Figure 3
Increased Ca2+-release activity evoked by
InsP3BM. (a,b) Traces of the Ca2+ changes
occurring at two Ca2+ spark sites in an
individual atrial myocyte (a) before or (b) 8 min
after application of 10 µM InsP3BM at room
temperature (20–22°C). Ca2+ sparks were
identified as brief signals (duration
~150 msec) with a spatial spread of ~2 µm.
The cellular locations from which the
responses were recorded are indicated by the
numbered circles on the small cell image
(blue) in (a). (c) The average effect of
incubation in 10 µM InsP3BM on Ca2+ spark
frequency (n = 8). In addition to increasing the
frequency of Ca2+ sparks as shown in (b),
InsP3BM also activated quiescent Ca2+ spark
sites (d,e). Ca2+ sparks occurring at
subsarcolemmal sites (origin of Ca2+ spark
was less than 1.5 µm from sarcolemma) are
marked by yellow dots on the cell image,
whereas Ca2+ sparks originating elsewhere
are marked with red dots. (f,g) The subcellular
distribution and Ca2+ spark frequency of the
active sites shown in (d) and (e) are illustrated
in (f) and (g), respectively.    Current Biology   
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Figure 2
Subcellular localisation of type II RyRs and
type II InsP3Rs in atrial myocytes. (a) Typical
immunofluorescence staining of type II RyRs.
The cartoon illustrates the structural
arrangement of junctional (dark green circles)
and non-junctional (light green circles) RyRs
on the sarcoplasmic reticulum (brown) as
indicated by the immunofluorescence staining.
(b–d) Double labelling of an atrial myocyte
with antibodies against (b) type II RyRs and
(c) type II InsP3Rs. (d) An overlay of the two
images shows co-localisation of the two
Ca2+-release channels, indicated in yellow.
Positions of isolated InsP3R immunoreactivity
are arrowed. (e,f) Volume-rendered image
showing (e) RyR and (f) InsP3R localisation in
a single double-labelled atrial myocyte. The
dashed and solid lines indicate the edge of
the cell, and the arrows point to identical
spots of RyR or InsP3R staining. Positive
staining for RyRs and InsP3Rs outside the cell
originated from adjacent cellular fragments.
See Supplementary material for movies
showing rotated 3D views of RyR and InsP3R
staining. Scale bars represent: (a) 2 µm;
(b) 10 µm; (e) 2 µm.
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in Figure 4b). For both experimental conditions (paced or
non-paced) we tested the specificity of the InsP3BM by
comparing the effect of the D-myo stereoisomer with that
of the L isomer. We found that the latter was biologically
inactive (data not shown), and only the former exerted
measurable responses from atrial myocytes.
There is little doubt that cardiac myocytes express type II
InsP3Rs. In the present study we found that these chan-
nels are functional and located in the same cellular regions
as the junctional RyRs that are involved in EC coupling
(Figure 2). Given the close proximity between the two
types of Ca2+-release channels, it is tempting to speculate
that Ca2+ released from InsP3Rs activates RyRs, and that
this cross-talk may underlie the ability of InsP3BM to acti-
vate Ca2+ sparks (Figure 3) and enhance EC coupling
(Figure 4). The positive inotropic effect of InsP3BM
observed in paced cells (Figure 4) resembles the effect of
some InsP3-generating hormones on cardiomyocytes [3].
As such hormones activate multiple signal transduction
cascades in the heart, it has been difficult to establish their
exact mode of action. Our data highlight the possibility
that InsP3Rs themselves may mediate at least some hor-
monal effects. The extra diastolic Ca2+ transients observed
upon InsP3BM stimulation (Figure 4) also resemble
responses of cardiac myocytes to InsP3-generating agonists,
namely their pro-arrhythmogenic action. Such extra Ca2+
transients are likely to be deleterious for the rhythm of the
heart, and are consistent with the suggestion that InsP3
may also have a pathological function in the heart [1]. 
Supplementary material
Supplementary material, including a detailed description of the Materi-
als and methods, and how Ca2+ sparks were distinguished, is available
at http://current-biology.com/supmat/supmatin.htm.
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Figure 4
Effect of InsP3BM on electrically paced atrial myocytes. Single atrial
myocytes paced at 0.3 Hz (30 V, 2 msec duration) were continually
perfused with either (a) control solution or (b) 10 µM InsP3BM at room
temperature (20–22°C). Similar results were found in six atrial myocytes.
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Supplementary movies
Movie 1
Rotating projection of the volume-rendered image of RyR II in Figure 2e.
Movie 2
Rotating projection of the volume-rendered image of InsP3R in Figure 2f.
Movie 3
Combined images of InsP3R (on left) and RyR II (on right).
Supplementary materials and methods
Cells
Rat ventricular and atrial myocytes were isolated as described previously
[S1]. For endothelial cells, the aorta was removed up to the bifurcation.
The vessel was opened, washed in RB (NaCl 135 mM, CaCl2 1.8 mM,
KCl 5.4 mM, MgCl2 2 mM, HEPES 15 mM, glucose 10 mM pH 7.4) and
the endothelium was mechanically removed from the aortic wall.
InsP3R isoform analysis
The ratio-PCR assay was based on the simultaneous amplification of
two or three InsP3R isoforms with identical primer-template sequences
as described earlier [S2] (35 cycles). Evaluation of the relative expres-
sion levels of different InsP3R isoforms was performed by digestion with
TagI and BglII restriction enzymes (Pharmacia), followed by separation
of the resulting fragments on 3% agarose gels. The bands were quanti-
fied with a GelDoc 1000 image analysis system (BioRad). Binding of
[3H]InsP3 to atrial and ventricular tissues was measured as described
elsewhere [S3], but with 50 µg of protein per assay. InsP3-induced
mobilization of intracellular Ca2+ stores of isolated atrial and ventricular
myocytes was measured as described elsewhere [S4]. The fluo3 fluo-
rescence was monitored using a LS-5 spectrometer (Perkin Elmer Life
Sciences) with excitation and emission wavelengths of 505 nm and
515 nm, respectively. The Kd of fluo3 was assumed to be 400 nM.
Antibodies
The monoclonal antibodies against type II InsP3Rs and type II RyRs
were kind gifts from K. Mikoshiba and V. Sorrentino, respectively.
Western blots were performed using standard procedures. For
immunostaining, isolated myocytes were attached to coverslips coated
with poly-D-lysine (Sigma) and then fixed with 4% paraformaldehyde for
1 h at room temperature. The immunohistochemical staining was per-
formed using established methods [S5]. The subcellular fluorescence
distribution of either Texas-Red or fluorescein-conjugated secondary
antibodies was investigated using an UltraView confocal microscopy
(Perkin Elmer Life Sciences). 3D volumes of the fluorescence were ren-
dered from z-stacks consisting of 95 confocal sections spaced at
300 nm using the ImageSuite software (Perkin Elmer Life Sciences).
Cytosolic Ca2+ measurements
Isolated atrial myocytes were attached to 40 mm glass coverslips coated
with poly-D-lysine (Sigma) and bathed in RB. Confocal Ca2+ measure-
ments with fluo3 were performed as described earlier [S6], with the
modification that we captured images (512 × 115 pixels) at an effective
rate of 30 frames sec–1 (after averaging four consecutive images taken
at 120 frames sec–1). The confocal slit was set to result in a z-section
thickness of ~1 µm. All experiments were performed at room tempera-
ture (20–22°C). For paced cells, cytosolic Ca2+ was monitored using
ratiometric Indo-1 measurements. Cells were electrically stimulated
using platinum electrodes 1 cm apart and equidistantly spaced from the
observed cell. Membrane-permeant InsP3 esters were used as
described earlier [S7,S8]. Essentially, the cells were continuously stimu-
lated with 10 µM myo-inositol 1,4,5-trisphosphate hexakis(butyry-
loxymethyl) ester (InsP3BM).
Determination of Ca2+ sparks
Using an image window size of 512 × 115 pixels allowed us to have
one, or a few, cardiomyocytes entirely in the field of view of our Noran
Oz laser scanning confocal microscope. Since Ca2+ sparks persist for
~100 msec, the sample rate of 33 msec per frame allowed us to detect
all Ca2+ sparks. A slight underestimation of the amplitude of the Ca2+
signal would likely be due to missing the peak of the response if it
occurred between frames. We used stringent criteria to distinguish
Ca2+ sparks from locally propagating Ca2+ waves. Ca2+ signals were
regarded as Ca2+ sparks when the Ca2+ rise reached a peak within 2
frames, their full-width at half-maximal amplitude was less than 4 µm
and their duration was less than 500 msec. As the boundary of an atrial
myocyte is obvious from the fluorescence image, the position of Ca2+
sparks within the cells was easy to determine. Ca2+ sparks were con-
sidered to be subsarcolemmal if they occurred within 1.5 µm of the
edge of the cell.
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